Dr.KSHAMA POPAT, Dr. RADHIKA NATARAJAN
Aim: To study refractive outcomes of Epi-LASIK in moderate myopia with Spherical Equivalent (SE) between -4.5 to -7.0 D (diopters).
Method: Retrospective, interventional study of 68 eyes of 39 patients, who had Epi-LASIK with Mitomycin C (MMC), in which primary outcome variables studied were uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), achievement of attempted correction , haze and regression.
Results: Pre operatively, mean SE was -5.79 ± 0.50. At 1 year final visit, mean SE was -0.03 ± 0.10, 85.9% eyes achieved UCVA of 20/20, 7.6% achieved 20/25, 3.8% achieved 20/30, 2.7% achieved 20/40. BCVA of 2 eyes was 20/30 and 1 eye 20/40. 62 eyes were within ± 0.75 D of attempted correction. 61 eyes had no haze, 4 had trace haze not affecting BCVA , 2 had grade 1 haze with BCVA 20/30 and 1 – grade 2 haze with BCVA 20/40. 6 eyes had regression of myopia ≥ – 0.75 D.
Conclusion: Epi-LASIK is safe, effective and predictable method for the treatment of moderate myopia.
Leave a Comment